Intermediate Risk PE: Why Should We Treat and What are the Best Treatment Options?
FACET
116 videos
Our mission is to provide a collaborative environment and educational opportunities for physicians, scientists, nurses, and medical professionals to discuss and teach advanced techniques, improve...
Read More
Our mission is to provide a collaborative environment and educational opportunities for physicians, scientists, nurses, and medical professionals to discuss and teach advanced techniques, improve clinical knowledge, and enhance the ability to provide excellent patient care, which ultimately improves patient health outcomes. To that end, the education program has strived to meet this goal educating and training the local, regional, and national medical community on the most recent advancements in medical science and research.
Speakers
Kenneth Rosenfield, MD, is the Section Head for Vascular Medicine and Intervention and Chairs the Acute Myocardial...
Kenneth Rosenfield, MD, is the Section Head for Vascular Medicine and Intervention and Chairs the Acute Myocardial Infarction (STEMI)Committee for the cardiac cath lab. He is a national leader in treatment of Carotid, Kidney, and Leg artery disease. Dr. Rosenfield is the Section Head for Vascular Medicine and Intervention, who specializes in complex cardiac and vascular interventions and directs the program for treatment of acute myocardial infarction (STEMI) in the cardiac catheterization laboratories. He has spearheaded the development of less-invasive therapies for patients with coronary and vascular disease, both at MGH and nationally, including treatment of Carotid, Kidney, and Leg artery narrowing using stents and other novel devices.
Related Videos
Start a conversation